This category provides an overview of regulatory frameworks and industry standards applicable to different regulated manufacturing sectors. It addresses regulatory expectations for medical devices, pharmaceutical and biopharmaceutical manufacturing, compounding outsourcing facilities, and cosmetic product manufacturing.
Content in this category is intended to help readers understand how regulatory requirements differ by industry and how those requirements influence validation, qualification, and compliance activities across the product lifecycle.
1. Introduction FDA inspections are structured regulatory investigations intended to evaluate whether a pharmaceutical manufacturer operates in a sustained state of compliance with current Good Manufacturing Practice requirements. These inspections assess not only written procedures and documentation, but also operational…
Cosmetic product manufacturing is subject to regulatory oversight intended to protect consumer safety and product quality, even though cosmetics are not regulated as drugs or medical devices. In the United States and other major markets, manufacturers are expected to implement…
503B compounding pharmacies, also referred to as outsourcing facilities, occupy a unique regulatory position within the U.S. healthcare system. These facilities compound sterile and non-sterile drug products for distribution without patient-specific prescriptions and are therefore subject to heightened regulatory oversight….
Regulatory validation requirements are central to maintaining control over biopharmaceutical manufacturing, where product quality cannot be assured by end testing alone. Biologics are inherently variable and sensitive to process conditions. As a result, regulators expect manufacturers to demonstrate, with documented…
Title 21 of the Code of Federal Regulations, Part 211, commonly referred to as current Good Manufacturing Practice cGMP regulations, establishes the minimum requirements for the manufacture, processing, packing, and holding of drug products intended for human use in the…
The Quality Management System Regulation (QMSR) is the current regulatory framework governing quality management system requirements for medical device manufacturers in the United States. Issued by the U.S. Food and Drug Administration, the QMSR replaces the former Quality System Regulation…
The Quality System Regulation QSR, established and enforced by the U.S. Food and Drug Administration, defines the mandatory quality system requirements for medical device manufacturers marketing products in the United States. QSR is codified in 21 CFR Part 820 and…
Quality System Regulation QSR — 21 CFR Part 820 21 CFR Part 820, commonly referred to as the Quality System Regulation QSR, establishes the regulatory baseline for the design, manufacture, packaging, labeling, storage, installation, and servicing of medical devices marketed…